Compare with Suven Life Sciences - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES SUVEN LIFE SCIENCES ZIM LABORATORIES/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 29.6 -10.1 - View Chart
P/BV x 1.2 16.1 7.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ZIM LABORATORIES   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-21
SUVEN LIFE SCIENCES
Mar-21
ZIM LABORATORIES/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs131109 120.6%   
Low Rs5319 273.1%   
Sales per share (Unadj.) Rs189.21.1 17,867.3%  
Earnings per share (Unadj.) Rs4.5-5.7 -79.5%  
Cash flow per share (Unadj.) Rs14.2-5.3 -267.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs99.05.6 1,772.3%  
Shares outstanding (eoy) m16.24127.28 12.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.560.6 0.8%   
Avg P/E ratio x20.5-11.3 -180.7%  
P/CF ratio (eoy) x6.5-12.0 -53.8%  
Price / Book Value ratio x0.911.5 8.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,4978,168 18.3%   
No. of employees `000NANA-   
Total wages/salary Rs m358185 193.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,073135 2,279.7%  
Other income Rs m2378 30.1%   
Total revenues Rs m3,096212 1,458.2%   
Gross profit Rs m346-799 -43.3%  
Depreciation Rs m15843 363.3%   
Interest Rs m1099 1,158.1%   
Profit before tax Rs m102-775 -13.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m29-53 -54.7%   
Profit after tax Rs m73-722 -10.1%  
Gross profit margin %11.3-593.1 -1.9%  
Effective tax rate %28.56.9 414.5%   
Net profit margin %2.4-535.3 -0.4%  
BALANCE SHEET DATA
Current assets Rs m1,9181,966 97.5%   
Current liabilities Rs m1,4201,098 129.4%   
Net working cap to sales %16.2643.8 2.5%  
Current ratio x1.41.8 75.4%  
Inventory Days Days162 676.9%  
Debtors Days Days858477 179.9%  
Net fixed assets Rs m1,304257 506.8%   
Share capital Rs m162127 127.6%   
"Free" reserves Rs m1,445584 247.6%   
Net worth Rs m1,608711 226.1%   
Long term debt Rs m2184 5,554.5%   
Total assets Rs m3,2222,223 144.9%  
Interest coverage x1.9-81.3 -2.4%   
Debt to equity ratio x0.10 2,456.3%  
Sales to assets ratio x1.00.1 1,573.1%   
Return on assets %5.7-32.0 -17.7%  
Return on equity %4.6-101.5 -4.5%  
Return on capital %11.6-107.1 -10.8%  
Exports to sales %67.469.1 97.6%   
Imports to sales %4.1547.1 0.8%   
Exports (fob) Rs m2,07293 2,226.1%   
Imports (cif) Rs m127737 17.3%   
Fx inflow Rs m2,14093 2,298.6%   
Fx outflow Rs m127737 17.3%   
Net fx Rs m2,012-644 -312.3%   
CASH FLOW
From Operations Rs m319-960 -33.2%  
From Investments Rs m-59558 -10.5%  
From Financial Activity Rs m-260349 -74.5%  
Net Cashflow Rs m-1-53 1.3%  

Share Holding

Indian Promoters % 33.3 60.0 55.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.9 -  
FIIs % 0.0 0.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 40.0 166.9%  
Shareholders   4,610 81,475 5.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   GLENMARK PHARMA  HEMO ORGANIC  AMRUTANJAN HEALTHCARE  JUBILANT PHARMOVA   DISHMAN PHARMA  



Today's Market

Sensex Snaps 2-Day Losing Streak, Zooms 887 Points, Nifty Settles Above 17,150; Tata Steel, Axis Bank Top Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

SUVEN LIFE SCIENCES 2020-21 Annual Report Analysis (Annual Result Update)

Nov 18, 2021 | Updated on Nov 18, 2021

Here's an analysis of the annual report of SUVEN LIFE SCIENCES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE SCIENCES. Also includes updates on the valuation of SUVEN LIFE SCIENCES.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZIM LABORATORIES SHARE PRICE


Dec 7, 2021 (Close)

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES 5-YR ANALYSIS

COMPARE ZIM LABORATORIES WITH

MARKET STATS